Get your health and wellness news from New Jersey
Provided by AGPTAMPA, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is closely monitoring reports of a hantavirus cluster linked to a cruise ship traveling in the Atlantic, which has resulted in multiple severe cases and fatalities. According to the World Health Organization Disease Outbreak News report published May 4, 2026, health authorities have identified seven confirmed and suspected cases, including three deaths, with additional passengers and crew under observation. Preliminary epidemiologic assessments indicate that initial exposure likely occurred prior to boarding, with the possibility of limited onboard secondary transmission under close-contact conditions. Importantly, global health authorities emphasize that the overall risk to the traveling public remains low.
Hantaviruses are a group of rodent-borne viruses typically transmitted through contact with contaminated environments, including inhalation of small dust particles contaminated with rodent urine, droppings, or saliva. Although human infections are uncommon, they can lead to severe illness, including hantavirus pulmonary syndrome (HPS), which may progress rapidly to respiratory failure. In the Americas, HPS has a reported case fatality rate of approximately 30 to 40 percent, underscoring the seriousness of infection once symptomatic, according to the Centers for Disease Control and Prevention. Unlike respiratory viruses such as influenza or COVID-19, hantaviruses are not typically spread from person-to-person, however direct human transmission has been documented for one hantavirus, the Andes virus, under conditions of prolonged, close contact. The Andes virus is endemic to Argentina, where the cruise ship departed three weeks ago.
This hantavirus infection cluster does not indicate a broader risk associated with cruise travel; rather, it reflects a localized, situational exposure event. Cruise ships, like other enclosed or semi-enclosed, crowded environments, require strong environmental health controls. There is no evidence to suggest that cruise travel itself increases the risk of hantavirus infection. Instead, the event highlights the importance of environmental exposure pathways, particularly in settings where rodent contact may occur prior to or during travel.
For the travel and cruise industry, this incident reinforces the importance of robust sanitation, rodent control, and environmental monitoring practices, as well as the need for rapid identification and response to infectious disease events. For travelers, preventive measures remain straightforward and effective: avoiding contact with rodent-contaminated areas, practicing good hand hygiene, and seeking medical care if symptoms such as fever, fatigue, or shortness of breath develop following potential exposure.
As Prof. Scott C. Weaver, MS, PhD, a GVN Center of Excellence director and the John Sealy Distinguished University Chair in Human Infections and Immunity at The University of Texas Medical Branch in the U.S., said, “This incident is not indicative of a widespread travel risk, but it is a clear example of how zoonotic viruses that come from wildlife exposure can surface in confined or connected settings. Hantavirus is primarily an environmental infection, and even in rare cases of human-to-human spread, it does not behave like highly transmissible respiratory viruses. The priority is vigilance, early identification, and clear, evidence-based communication.”
Prof. Emma Thomson, director of the MRC–University of Glasgow Centre for Virus Research, a GVN Center of Excellence in the UK, said, “This incident highlights how zoonotic viruses can emerge in confined or highly connected settings such as cruise ships. Hantaviruses are typically acquired through environmental exposure to rodent excreta; however, the key concern in this situation is the possible involvement of Andes virus, which is the only hantavirus known to transmit between humans, particularly in close-contact settings. This virus has been well described in southern Argentina, and further urgent diagnostic testing is required to confirm this or another hantavirus as the cause of the outbreak. Reports of infection among crew members and the duration of the cluster raise the possibility of ongoing transmission, although this remains to be confirmed. Given the incubation period of hantavirus infection, further cases may yet emerge. At this stage, the priority is to implement precautionary public health measures, including respiratory protection, strict hand hygiene, and isolation of suspected cases, alongside rapid diagnostic work to identify the virus involved. Specialist centres, including the MRC–University of Glasgow Centre for Virus Research, have the capability to support confirmatory diagnostics and characterisation if required. Clear communication and early intervention are essential while the epidemiology is still being defined.”
Globally, hantavirus infections occur sporadically and vary by region. In the Americas, cases are often associated with rural or outdoor exposures, while in Europe and Asia, different hantavirus strains are linked to renal disease. The current cluster appears to be limited in scope, but it underscores a broader reality. Zoonotic viruses remain an ongoing and unpredictable component of the global health landscape.
The Global Virus Network emphasizes that events such as this should prompt awareness rather than alarm. Continued investment in international surveillance, research, and preparedness, along with clear communication between public health authorities, the travel industry, and the public, remains essential to managing the risks associated with hantavirus and other emerging infectious diseases.
Media Contacts:
Nora Samaranayake
nsamaranayake@gvn.org
Global Virus Network
About the Global Virus Network
The Global Virus Network (GVN) is a worldwide coalition comprising 90+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies. GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.